查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403412

到 2030 年痤疮治疗市场预测：按产品、痤疮类型、药物类型、治疗方法、给药途径、最终用户和地区进行的全球分析

Acne Treatment Market Forecasts to 2030 - Global Analysis By Product (Isotretinoi, Antibiotics, Retinoids and Other Products), Acne Type, Drug Type, Treatment, Route of Administration, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球痤疮治疗市场规模为 111 亿美元，预计在预测期内将以 7.1% 的复合年增长率增长，并在 2030 年达到 180 亿美元。

皮肤毛孔和开口（包括毛囊）堵塞是痤疮（一种与皮肤相关的疾病）的原因。青少年和成年早期的人是表现出这种位置的主要人群。这是一种非常常见的皮肤病，影响所有皮肤类型，无论年龄如何。抗生素和类视色素A用于治疗此类皮肤病。儘管缺乏证据表明治疗这些皮肤状况会产生预期的效果，但由于其美容价值，该行业长期以来一直主导着该领域。

根据美国国家生物技术资讯中心 (NCBI) 的数据，到 2022 年，痤疮的盛行率将影响全球 9.4% 的人口。它是世界上第八常见的疾病。

促进生长的因素：痤疮盛行率增加

皮肤病影响很多人。随着众多用于治疗的产品（例如类类视色素A、类视色素A以及口服和局部抗生素）的出现，全球大众对痤疮产品和现成的治疗方法选择的认识越来越强。因此，提高患者意识预计将推动市场扩张。有效的产品行销激发目标受众的兴趣也是促进市场拓展的关键因素。

成长抑制因素：对产品安全的担忧

根据给药和给药方法，痤疮治疗药物可能会产生各种副作用。皮肤发炎和干燥是局部性痤疮治疗最常见的副作用。内服药物可能有更严重的副作用。抗生素会引起噁心、呕吐、头晕和轻微头痛。围绕痤疮治疗药物的安全性担忧预计​​将阻碍市场扩张。

机会：提高认识

对微创美容疗程的需求不断增长。皮肤科医生更喜欢透过局部治疗和微创手术而不是手术治疗来治疗皮肤病。由于更好的决策、改善的患者与医生的联繫以及详细记录的程序，对脸部和皮肤相关问题的治疗需求正在增加。这鼓励了使用较少疼痛的美容组合治疗方法。

威胁：治疗费用高

有效的痤疮治疗有时可能很昂贵，特别是当涉及处方药和雷射治疗等手术时。对于财力有限或没有保险的人来说，这是一个严重的缺点。痤疮治疗可能不是一次性费用。有些治疗方法需要定期维护和追踪预约，这会增加整体成本。这些因素阻碍了市场的成长。

COVID-19 的影响

由于全球寻求治疗的人数减少，痤疮治疗药物的成长速度因疫情而放缓。由于COVID-19的影响，该行业的主要公司收入大幅下降。药品销售也受到生产减少、医疗支出重新分配、供应链中断、皮肤科诊所关闭和其他问题的影响。与长期使用医用口罩相关的痤疮爆发增加进一步增加了对药品的需求。

预计治疗设备领域在预测期内将是最大的。

预计治疗设备领域在预测期内将是最大的。痤疮治疗设备的开发正在推动该行业的扩张。雷射治疗痤疮疤痕的目的是减少以前痤疮发作留下的疤痕。涂抹在皮肤真皮层的持续光疗会破坏疤痕组织并促进新的健康皮肤细胞的生长以取代受损的组织。

预计类类视色素A产业在预测期内复合年增长率最高

预计类类视色素A细分市场在预测期内复合年增长率最高。类视色素A现在被广泛用于去除毛孔中多余的皮脂和灰尘。这种方法被认为是安全的，几乎没有副作用，使其成为一个很大的市场领域。它的作用是阻止死皮细胞堵塞毛孔，这是痤疮的主要原因。透过促进细胞更新，类视色素A的产生可以防止毛孔堵塞。

比最大的地区

由于该地区痤疮患者数量不断增加以及与美容相关的消费者担忧不断增加，预计北美将在预测期内占据最大的市场占有率。由于该地区主要企业推出新产品以及患者人数显着增加，该市场将成长。随着创新治疗方法和解决方案的使用越来越频繁，市场占有率可能会扩大到更高的数量。

复合年增长率最高的地区

由于市场参与企业数量不断增加以及公众对多种药物的认识不断增强，预计亚太地区在预测期内将保持最高的复合年增长率。该地区拥有最大的各种旨在实现美丽肌肤的化妆品的基本客群。由于气候原因，色素沉着也被认为是该地区的重要议题。此外，预测期内消费药品使用量的增加将推动成长。

免费客製化服务

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 公司之间的竞争关係

第五章全球痤疮治疗市场：副产品

  • 类视色素
  • 抗生素
  • 类视色素A
  • 其他产品

第六章全球痤疮治疗市场：按痤疮类型

  • 适度
  • 温和的
  • 中度至重度

第七章全球痤疮治疗市场：依药物类型

  • 处方笺
  • 店面销售(OTC)

第八章全球痤疮治疗市场：依治疗方法

  • 装置
    • 高频装置
    • 雷射装置
  • 治疗性治疗
    • 发炎药
    • 化学换肤
    • 荷尔蒙药物
    • 类视色素A疗法
    • 抗生素
  • 其他治疗方法

第九章全球痤疮治疗市场：依给药途径

  • 口服
  • 可注射的
  • 局部的

第10章全球痤疮治疗市场：依最终用户分类

  • 医疗水疗中心
  • 皮肤科诊所
  • 医院
  • 其他最终用户

第十一章全球痤疮治疗市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司简介

  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Leo Pharma A/S
  • Stiefel Laboratories, Inc.
  • Bayer AG
  • Roche Holding AG
  • Bausch Health Companies Inc.
  • Galderma Laboratories
  • Hoffman La Roche Ltd
  • Pfizer Inc.
  • Valeant Pharmaceutical International, Inc.
  • GlaxoSmithKline Plc.
  • Cutera Inc.
  • Vyne Therapeutics Inc.
  • Botanix Pharmaceuticals
  • ABBVIE INC.
  • Candela Corporation
  • Almirall, SA
Product Code: SMRC24637

According to Stratistics MRC, the Global Acne Treatment Market is accounted for $11.1 billion in 2023 and is expected to reach $18.0 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Clogged skin pores and openings, including hair follicles, are the cause of acne, a skin-related condition. Teenagers and those in their early adult years are the key demographics that exhibit this arrangement. This is an extremely prevalent skin condition that affects all skin types regardless of age. Antibiotics and retinoids are used in the treatment of this type of skin condition. Even though there is no certainty that treating these skin conditions would provide the desired effects, the industry has long dominated this field due to its cosmetic value.

According to the National Center for Biotechnology Information (NCBI), the prevalence of acne affected 9.4% of the global population in 2022. It is the eighth most prevalent disease in the world.

Market Dynamics:

Driver:

Increasing prevalence of acne

Skin disorders affect a large percentage of people. The worldwide public is becoming more aware of acne products and accessible treatment choices due to the advent of numerous products used for the treatment, such as retinoids, isotretinoids, and oral and topical antibiotics. Therefore, it is anticipated that rising patient awareness would promote market expansion. Effective product marketing to pique the interest of the intended audience is also a key component in driving market expansion.

Restraint:

Concerns about product safety

Treatments for acne might have different side effects according on the dosage and mode of administration. Skin irritation and dryness are the most frequent adverse effects of topical acne medications. More severe adverse effects are possible with oral medicines. Antibiotics may cause nausea or vomiting, as well as dizziness and light headedness. It is anticipated that the safety concerns surrounding acne treatment solutions would impede market expansion.

Opportunity:

Increasing awareness

The demand for minimally invasive cosmetic treatment treatments is increasing. Dermatologists would rather use topical treatments or less invasive techniques to address skin conditions than surgical ones. The need for treatments connected to face and skin-related issues is rising as a result of better decision-making, improved patient-physician connections, and well-documented procedures. This has prompted the use of less painful cosmetic combination treatment methods.

Threat:

High cost of treatment

Effective acne treatments can occasionally be costly, particularly when it comes to prescription drugs or procedures like laser therapy. This is a serious drawback for people with little resources or no insurance. Treatments for acne might not be a one-time expense. The overall cost of some procedures is increased by the need for regular maintenance or follow-up appointments. These factors are hampering the growth of the market.

COVID-19 Impact:

The epidemic slowed the rise of acne medications since fewer people worldwide were seeking treatment. Leading companies in the industry experienced significant revenue losses as a result of COVID-19. Drug sales were also impacted by reduced manufacturing, redistributing healthcare spending, broken supply chains, shutting dermatological clinics, and other issues. The rise in acne occurrences linked to extended usage of medical face masks further contributed to the demand for pharmaceuticals.

The therapeutic devices segment is expected to be the largest during the forecast period

The therapeutic devices segment is expected to be the largest during the forecast period. The development of therapeutic gadgets for the treatment of acne is propelling this industry's expansion. Reducing the visibility of scars from previous acne episodes is the goal of laser therapy for acne scars. Continuous light therapy is applied to the skin's dermis layer to break up scar tissue and promote the growth of new, healthy skin cells to replace the damaged tissue.

The retinoid segment is expected to have the highest CAGR during the forecast period

The retinoid segment is expected to have the highest CAGR during the forecast period. Retinoids are now widely used by people to clear their skin of excess oil and dust that has clogged their open pores. The method is a large market sector since it is regarded as safe and has little negative effects. They function by stopping the main cause of acne, dead skin cells, from obstructing pores. By encouraging cell turnover, retinoid production keeps the pores from becoming clogged.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the region's increasing majority of acne and growing consumer problems related to beauty. The market will grow as a result of the introduction of new products by significant regional companies and a notable increase in the patient population. The market share will increase to a bigger volume as innovative treatments and solutions are used more frequently.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to rising awareness among the population about several drugs combined with the increasing number of companies entering the market. The greatest customer base for a variety of cosmetic goods created to achieve clean skin is found in this region. Due to the climate, hyperpigmentation has also been identified as a significant issue in this area. Moreover, growth would be fueled by consumers' increasing medicine usage over the projection period.

Key players in the market:

Some of the key players in Acne Treatment market include Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Leo Pharma A/S, Stiefel Laboratories, Inc., Bayer AG, Roche Holding AG, Bausch Health Companies Inc., Galderma Laboratories, Hoffman La Roche Ltd, Pfizer Inc., Valeant Pharmaceutical International, Inc., GlaxoSmithKline Plc., Cutera Inc., Vyne Therapeutics Inc., Botanix Pharmaceuticals, ABBVIE INC., Candela Corporation and Almirall, S.A.

Key Developments:

In July 2022, Glenmark Pharmaceuticals launched a new acne drug, MINYM gel, in India. This is India's first topical Minocycline 4% Gel to treat acne.

In March 2022, Galderma introduced its breakthrough skincare cream, Twyneo to treat moderate to severe facial acne, to the U.S. market at the American Academy of Dermatology (AAD) Annual Meeting.

In January 2022, GALDERMA announced to receive its antitrust clearance from the U.S. authorities after completing the acquisition of ALASTIN Skincare, Inc. for developing innovative and clinically-tested physician-dispensed skincare products.

Products Covered:

  • Isotretinoi
  • Antibiotics
  • Retinoids
  • Other Products

Acne Types Covered:

  • Moderate
  • Mild
  • Moderate to Severe

Drug Types Covered:

  • Prescription
  • Over the Counter (OTC)

Treatments Covered:

  • Devices
  • Therapeutic Treatment
  • Other Treatments

Route of Administrations Covered:

  • Oral
  • Injectable
  • Topical

End Users Covered:

  • MedSpa
  • Dermatology Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Acne Treatment Market, By Product

  • 5.1 Introduction
  • 5.2 Isotretinoi
  • 5.3 Antibiotics
  • 5.4 Retinoids
  • 5.5 Other Products

6 Global Acne Treatment Market, By Acne Type

  • 6.1 Introduction
  • 6.2 Moderate
  • 6.3 Mild
  • 6.4 Moderate to Severe

7 Global Acne Treatment Market, By Drug Type

  • 7.1 Introduction
  • 7.2 Prescription
  • 7.3 Over the Counter (OTC)

8 Global Acne Treatment Market, By Treatment

  • 8.1 Introduction
  • 8.2 Devices
    • 8.2.1 Radio frequency Devices
    • 8.2.2 Laser Devices
  • 8.3 Therapeutic Treatment
    • 8.3.1 Anti-inflammatory Drugs
    • 8.3.2 Chemical Peels
    • 8.3.3 Hormonal Drugs
    • 8.3.4 Retinoid Therapy
    • 8.3.8 Antibiotics
  • 8.4 Other Treatments

9 Global Acne Treatment Market, By Route of Administration

  • 9.1 Introduction
  • 9.2 Oral
  • 9.3 Injectable
  • 9.4 Topical

10 Global Acne Treatment Market, By End User

  • 10.1 Introduction
  • 10.2 MedSpa
  • 10.3 Dermatology Clinics
  • 10.4 Hospitals
  • 10.5 Other End Users

11 Global Acne Treatment Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Johnson & Johnson Services, Inc.
  • 13.2 Teva Pharmaceutical Industries Ltd.
  • 13.3 Leo Pharma A/S
  • 13.4 Stiefel Laboratories, Inc.
  • 13.5 Bayer AG
  • 13.6 Roche Holding AG
  • 13.7 Bausch Health Companies Inc.
  • 13.8 Galderma Laboratories
  • 13.9 Hoffman La Roche Ltd
  • 13.10 Pfizer Inc.
  • 13.11 Valeant Pharmaceutical International, Inc.
  • 13.12 GlaxoSmithKline Plc.
  • 13.13 Cutera Inc.
  • 13.14 Vyne Therapeutics Inc.
  • 13.15 Botanix Pharmaceuticals
  • 13.16 ABBVIE INC.
  • 13.17 Candela Corporation
  • 13.18 Almirall, S.A.

List of Tables

  • Table 1 Global Acne Treatment Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Acne Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Acne Treatment Market Outlook, By Isotretinoi (2021-2030) ($MN)
  • Table 4 Global Acne Treatment Market Outlook, By Antibiotics (2021-2030) ($MN)
  • Table 5 Global Acne Treatment Market Outlook, By Retinoids (2021-2030) ($MN)
  • Table 6 Global Acne Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 7 Global Acne Treatment Market Outlook, By Acne Type (2021-2030) ($MN)
  • Table 8 Global Acne Treatment Market Outlook, By Moderate (2021-2030) ($MN)
  • Table 9 Global Acne Treatment Market Outlook, By Mild (2021-2030) ($MN)
  • Table 10 Global Acne Treatment Market Outlook, By Moderate to Severe (2021-2030) ($MN)
  • Table 11 Global Acne Treatment Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 12 Global Acne Treatment Market Outlook, By Prescription (2021-2030) ($MN)
  • Table 13 Global Acne Treatment Market Outlook, By Over the Counter (OTC) (2021-2030) ($MN)
  • Table 14 Global Acne Treatment Market Outlook, By Treatment (2021-2030) ($MN)
  • Table 15 Global Acne Treatment Market Outlook, By Devices (2021-2030) ($MN)
  • Table 16 Global Acne Treatment Market Outlook, By Radio frequency Devices (2021-2030) ($MN)
  • Table 17 Global Acne Treatment Market Outlook, By Laser Devices (2021-2030) ($MN)
  • Table 18 Global Acne Treatment Market Outlook, By Therapeutic Treatment (2021-2030) ($MN)
  • Table 19 Global Acne Treatment Market Outlook, By Anti-inflammatory Drugs (2021-2030) ($MN)
  • Table 20 Global Acne Treatment Market Outlook, By Chemical Peels (2021-2030) ($MN)
  • Table 21 Global Acne Treatment Market Outlook, By Hormonal Drugs (2021-2030) ($MN)
  • Table 22 Global Acne Treatment Market Outlook, By Retinoid Therapy (2021-2030) ($MN)
  • Table 23 Global Acne Treatment Market Outlook, By Antibiotics (2021-2030) ($MN)
  • Table 24 Global Acne Treatment Market Outlook, By Other Treatments (2021-2030) ($MN)
  • Table 25 Global Acne Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 26 Global Acne Treatment Market Outlook, By Oral (2021-2030) ($MN)
  • Table 27 Global Acne Treatment Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 28 Global Acne Treatment Market Outlook, By Topical (2021-2030) ($MN)
  • Table 29 Global Acne Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Acne Treatment Market Outlook, By MedSpa (2021-2030) ($MN)
  • Table 31 Global Acne Treatment Market Outlook, By Dermatology Clinics (2021-2030) ($MN)
  • Table 32 Global Acne Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 33 Global Acne Treatment Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

11 Global Acne Treatment Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies